598 related articles for article (PubMed ID: 30425649)
1. Diabetic Cardiomyopathy: Current and Future Therapies. Beyond Glycemic Control.
Borghetti G; von Lewinski D; Eaton DM; Sourij H; Houser SR; Wallner M
Front Physiol; 2018; 9():1514. PubMed ID: 30425649
[TBL] [Abstract][Full Text] [Related]
2. Asymptomatic Diabetic Cardiomyopathy: an Underrecognized Entity in Type 2 Diabetes.
Stanton AM; Vaduganathan M; Chang LS; Turchin A; Januzzi JL; Aroda VR
Curr Diab Rep; 2021 Sep; 21(10):41. PubMed ID: 34580767
[TBL] [Abstract][Full Text] [Related]
3. An Insight into the Pathogenesis of Diabetic Cardiomyopathy Along with the Novel Potential Therapeutic Approaches.
Vig H; Ravinandan AP; Vishwas HN; Tyagi S; Rathore S; Wal A; Wal P
Curr Diabetes Rev; 2024; 20(1):e020523216416. PubMed ID: 37138437
[TBL] [Abstract][Full Text] [Related]
4. Endothelial Dysfunction and Diabetic Cardiomyopathy.
Wang M; Li Y; Li S; Lv J
Front Endocrinol (Lausanne); 2022; 13():851941. PubMed ID: 35464057
[TBL] [Abstract][Full Text] [Related]
5. Diabetic Cardiomyopathy: An Update of Mechanisms Contributing to This Clinical Entity.
Jia G; Hill MA; Sowers JR
Circ Res; 2018 Feb; 122(4):624-638. PubMed ID: 29449364
[TBL] [Abstract][Full Text] [Related]
6. Role of AMP-activated protein kinase on cardio-metabolic abnormalities in the development of diabetic cardiomyopathy: A molecular landscape.
Haye A; Ansari MA; Rahman SO; Shamsi Y; Ahmed D; Sharma M
Eur J Pharmacol; 2020 Dec; 888():173376. PubMed ID: 32810493
[TBL] [Abstract][Full Text] [Related]
7. Are targeted therapies for diabetic cardiomyopathy on the horizon?
Tate M; Grieve DJ; Ritchie RH
Clin Sci (Lond); 2017 May; 131(10):897-915. PubMed ID: 28473471
[TBL] [Abstract][Full Text] [Related]
8. Mechanisms of cardiac dysfunction in diabetic cardiomyopathy: molecular abnormalities and phenotypical variants.
Prandi FR; Evangelista I; Sergi D; Palazzuoli A; Romeo F
Heart Fail Rev; 2023 May; 28(3):597-606. PubMed ID: 35001338
[TBL] [Abstract][Full Text] [Related]
9. Diabetic cardiomyopathy--fact or fiction?
Maisch B; Alter P; Pankuweit S
Herz; 2011 Mar; 36(2):102-15. PubMed ID: 21424347
[TBL] [Abstract][Full Text] [Related]
10. The diabetic cardiomyopathy.
Tarquini R; Lazzeri C; Pala L; Rotella CM; Gensini GF
Acta Diabetol; 2011 Sep; 48(3):173-81. PubMed ID: 20198391
[TBL] [Abstract][Full Text] [Related]
11. Clinical Approach to Diabetic Cardiomyopathy: A Review of Human Studies.
Tarquini R; Pala L; Brancati S; Vannini G; De Cosmo S; Mazzoccoli G; Rotella CM
Curr Med Chem; 2018; 25(13):1510-1524. PubMed ID: 28685679
[TBL] [Abstract][Full Text] [Related]
12. Emerging Therapy for Diabetic Cardiomyopathy: From Molecular Mechanism to Clinical Practice.
Hsuan CF; Teng SIF; Hsu CN; Liao D; Chang AJ; Lee HL; Hee SW; Chang YC; Chuang LM
Biomedicines; 2023 Feb; 11(3):. PubMed ID: 36979641
[TBL] [Abstract][Full Text] [Related]
13. Pathophysiology and Treatment of Diabetic Cardiomyopathy and Heart Failure in Patients with Diabetes Mellitus.
Nakamura K; Miyoshi T; Yoshida M; Akagi S; Saito Y; Ejiri K; Matsuo N; Ichikawa K; Iwasaki K; Naito T; Namba Y; Yoshida M; Sugiyama H; Ito H
Int J Mol Sci; 2022 Mar; 23(7):. PubMed ID: 35408946
[TBL] [Abstract][Full Text] [Related]
14. The role of hyperglycaemia in the development of diabetic cardiomyopathy.
El Hayek MS; Ernande L; Benitah JP; Gomez AM; Pereira L
Arch Cardiovasc Dis; 2021 Nov; 114(11):748-760. PubMed ID: 34627704
[TBL] [Abstract][Full Text] [Related]
15. Approaches to prevention of cardiovascular complications and events in diabetes mellitus.
Coccheri S
Drugs; 2007; 67(7):997-1026. PubMed ID: 17488145
[TBL] [Abstract][Full Text] [Related]
16. Exploring the Complex Relationship between Diabetes and Cardiovascular Complications: Understanding Diabetic Cardiomyopathy and Promising Therapies.
Ghosh N; Chacko L; Bhattacharya H; Vallamkondu J; Nag S; Dey A; Karmakar T; Reddy PH; Kandimalla R; Dewanjee S
Biomedicines; 2023 Apr; 11(4):. PubMed ID: 37189744
[TBL] [Abstract][Full Text] [Related]
17. [Diabetic cardiomyopathy--a type of coronary artery disease?].
Stratmann B; Stork I; Tschoepe D
Internist (Berl); 2008 Apr; 49(4):436-40. PubMed ID: 18301873
[TBL] [Abstract][Full Text] [Related]
18. Role of differential signaling pathways and oxidative stress in diabetic cardiomyopathy.
Watanabe K; Thandavarayan RA; Harima M; Sari FR; Gurusamy N; Veeraveedu PT; Mito S; Arozal W; Sukumaran V; Laksmanan AP; Soetikno V; Kodama M; Aizawa Y
Curr Cardiol Rev; 2010 Nov; 6(4):280-90. PubMed ID: 22043204
[TBL] [Abstract][Full Text] [Related]
19. Diabetic cardiomyopathy: ongoing controversies in 2012.
Seferović PM; Milinković I; Ristić AD; Seferović Mitrović JP; Lalić K; Jotić A; Kanjuh V; Lalić N; Maisch B
Herz; 2012 Dec; 37(8):880-6. PubMed ID: 23223771
[TBL] [Abstract][Full Text] [Related]
20. Diabetic cardiomyopathy: a hyperglycaemia- and insulin-resistance-induced heart disease.
Jia G; Whaley-Connell A; Sowers JR
Diabetologia; 2018 Jan; 61(1):21-28. PubMed ID: 28776083
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
